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Abstract: Pseudaminic acids (Pse) are a group of non-mammalian 
nonulosonic acids (NulOs) that have been shown as an important 
virulence factor for a number of pathogenic bacteria, including 
emerging multidrug resistant ESKAPE pathogens. Despite their 
discovery over 30 years ago, relatively little is known about the 
biological significance of Pse glycans compared to their sialic acid 
analogues, primarily due to a lack of access to the synthetically 
challenging Pse architecture. Recently however the Pse backbone 
has been subjected to increasing synthetic exploration by 
carbohydrate (bio)chemists, and the total synthesis of complex Pse 
glycans achieved using inspiration from the biosynthesis and 
subsequent detailed study of the chemical glycosylation using Pse 
donors. In this minireview we provide context for these efforts by 
summarising the recent synthetic approaches pioneered for 
accessing Pse glycans, which are set to open up this underexplored 
area of glycoscience to the wider scientific community. 
1. Introduction 
At the beginning of the millennium, sugars were defined as the 
³&LQGHUHOOD´ PROHFXOHV RI ELRORJ\; the neglected, over-looked 
sister of the nucleic acids and proteins.[1] Recently however the 
ubiquity of glycosylation and glycans has become apparent and 
it is now accepted that sugars play essential roles in biology 
beyond that of an energy source. [2] Nevertheless, glycan 
structure and function still remains relatively unexplored in many 
forms of life including bacteria, archaea, fungi and algae, and 
until recently many classes of glycosylation were believed to be 
reserved as a eukaryotic post-translational modification. The 
discovery of the Pgl pathway within Campylobacter jejuni was 
the first example of a general N-linked glycosylation pathway in 
prokaryotes,[3] and a significant breakthrough in the field of 
bacterial glycobiology. The types of monosaccharide found in 
bacteria show greater diversity than eukaryotic 
monosaccharides and often undergo an extensive range of 
chemical modifications (including alkylation, acylation, 
aminoacylation and phosphorylation).[4]  
Key cell-surface glycoconjugates in Gram-negative bacteria 
include peptidoglycan, lipopolysaccharide (LPS), 
lipooligosaccharide (LOS), extracellular polysaccharide (EPS), 
capsular polysaccharide (CPS) and glycoproteins, whilst Gram-
positive bacteria do not contain LPS or LOS but do have 
glycosylated lipoteichoic acids and wall teichoic acids.[4]  
Perhaps one of the most intriguing biological roles of bacterial 
sugars is in ³PROHFXODU PLPLFU\´ ZKHUHLQ microbial pathogens 
cover their surfaces with glycans that are similar to the hosts, 
with the aim of evading host immune responses or increasing 
host tolerance towards the pathogen.[2a] This is observed with 
the nonulosonic acids (nulOs),[5] a sub-group of nine carbon D-
keto acid sugars, some of which are found as terminal residues 
in human glycoconjugates and often in bacterial 
glycoconjugates.[6] A well-studied sub-class of these sugars are 
the sialic acids, of which over 50 naturally occurring derivatives 
have been identified.[7] Sialic acids can be found in all three 
domains of life, and include ubiquitous 2-keto-3-deoxy-5-
acetamido-D-glycero-D-galacto-nonulosonic acid (N-acetyl-
neuraminic acid, Neu5Ac 1, Figure 1a).[8] 
2. Occurrence and biological significance of 
Pseudaminic acid glycans 
A less common group of nulOs which are of particular interest 
are pseudaminic acids (Pse). TKHVH³VLDOLFDFLG-OLNH´sugars are 
not present in mammalian cells, but have been found in many 
bacterial species.[5, 9] The general term pseudaminic acid arose 
IURP WKH LQLWLDO GLVFRYHU\ RI Į-5,7-diacetamido-3,5,7,9-
tetradeoxy-L-glycero-L-manno-non-2-ulosonic acid (Pse5Ac7Ac 
2, Figure 1a), within the LPS O-antigen of Pseudomonas 
aeruginosa O7 and O9.[10] Pse5Ac7Ac 2 varies from Neu5Ac 1 
in stereochemistry at carbons 5, 7 and 8 and functionality at 7 
and 9. Derivatives of Pse5Ac7Ac 2 have since been 
characterised in which N-linked substituents at C5 and C7 can 
show wide diversity (Figure 1b),[5] and the Bacterial 
Carbohydrate Structure Database currently lists 149 bacterial 
glycan structures in which Pse5Ac7Ac 2 or a derivative is 
present (http://csdb.glycoscience.ru/bacterial/) (May 2019). Pse 
glycoconjugates have also been identified in human gut archaea 
Methanobrevibacter smithii, where Pse5Ac7Ac 2 is present in 
the CPS.[11] Although putative nulO biosynthesis genes have 
also been found in several other species of archaea, complete 
pathways within these genomes are yet to be assigned. [11b] 
Unlike Neu5Ac 1 which is most commonly a terminal glycan 
residue, Pse is predominantly found as an internal component of 
glycoconjugates, although there are some examples of terminal 
Pse residues.[12]  
Pse glycoconjugates are notably present in the LPS and CPS of 
many pathogenic bacteria, including nosocomial pathogens P. 
aeruginosa and Acinetobacter baumannii.[9a, 9c, 9e, 10, 12-13] 
Furthermore serine and threonine residues of flagella and pili 
may be O-glycosylated with Pse.[10, 12, 14] For example, in the 
gastric pathogen Helicobacter pylori, flagella are exclusively 
glycosylated with Pse5Ac7Ac 2 and experimental evidence has 
shown that disruption of flagellin glycosylation resulted in a loss 
of bacterial motility due to a lack of detectable flagella. [15] 
Similarly in C. jejuni, the leading cause of gastroenteritis, the 
FlaA1 flagellin protein is also glycosylated with Pse at multiple 
residues,[14a] and mutation of these residues resulted in 
truncated flagella and reduced motility.[16] It has been 
Figure 1. a. Ubiquitous sialic acid Neu5Ac 1, and nonulosonic acid 
Pse5Ac7Ac 2. b. Naturally occuring Pse derivatives, modified at N5 and N7. 
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demonstrated that host immune responses to C. jejuni may be 
dampened by the presence of the cell surface Pse modified 
flagella, which were shown to bind to the human immune-
modulatory receptor siglec-10, resulting in increased murine 
dendritic cell interleukin-10 expression.[6] As both motility and a 
capacity to evade host immune response are established key 
virulence factors in the ability of pathogenic bacteria to colonize 
the host,[17] novel therapeutics with the potential to prevent 
bacterial presentation of Pse are therefore clearly of critical 
significance. However, further exploration of this area of 
glycoscience has been severely hampered by limited access to 
Pse based glycans and probes. In this review, we summarise 
recent ground breaking work in the field of Pse glycan synthesis, 
which is set to open up the study of Pse glycobiology to the 
wider scientific community.   
3. Biosynthesis of pseudaminic acids 
The biosynthetic pathways of nucleotide-activated Į-CMP-
Pse5Ac7Ac 3 and its derivatives have been proposed in multiple 
organisms including multidrug resistant pathogens (all pathways 
described in this section are depicted in Scheme 1). These 
organisms include the aforementioned C. jejuni and H. pylori, 
ZKHUH WKH Į-CMP-Pse5Ac7Ac 3 biosynthetic pathways have 
been well characterised in vitro. [9b, 18] The biosynthesis of CMP-
Pse has a number of features common to the biosynthesis of all 
CMP-nulOs, and have proved inspiring for novel chemical 
approaches, vide infra. In all CMP-nulO biosynthesis pathways 
an activated hexose is initially utilised, in Pse biosynthesis this is 
UDP-GlcNAc 4. Varying numbers of steps including hydrolysis of 
the nucleotide are required to convert the activated hexose into 
the desired hexose, before condensation with a three-carbon 
substrate, phosphoenol pyruvate (PEP), yields a nulO. Finally, 
all nulOs are activated at the anomeric position to form reactive 
glycosyl donors. In vivo this is often through installation of a 
cytidine monophosphate group (CMP), and this CMP-donor then 
acts as a substrate for glycosyltransferase enzyme (GTs) which 
incorporate the NulO into glycoconjugates.[5] 
Typically, within Gram-QHJDWLYHEDFWHULDELRV\QWKHVLVRIĮ-
CMP-Pse5Ac7Ac 3 and its derivatives 5 and 6 is performed in 
five, six or seven enzymatic steps.[18a] In C. jejuni and H. pylori, 
the UDP-GlcNAc 4 starting material is dehydrated and 
epimerised by PseB to yield ketone 7, the substrate for L-
glutamine dependent aminotransferase PseC, which 
subsequently affords 4-amino-AltNAc sugar 8.[19] N-
acetyltransferase, PseH, then uses amine 8 and acetyl-
coenzyme A (Ac-CoA) to afford acetylated 9, which then 
undergoes hydrolysis of UDP, facilitated by nucleotidase PseG, 
yielding the key biosynthetic intermediate 6-deoxy-AltdiNAc 10. 
A pseudaminic acid synthase, PseI, then utilises PEP to convert 
10 to the nulO Pse5Ac7Ac 2 in an aldol condensation, a strategy 
often mirrored in chemical syntheses of QLQHFDUERQĮ-keto acid 
sugars. The sixth enzyme in this biosynthetic pathway, CMP-
synthetase PseF, finally installs the CMP-moiety at the anomeric 
hydroxyl, using CTP to afford the CMP-Pse5Ac7Ac 3 glycosyl 
donor. This biosynthetic route differs slightly in the human 
pathogen Aeromonas caviae, where only five enzymes are 
required due to the dual-functionality of FlmD which performs 
the acetyl-transferase and UDP-hydrolase roles which are 
carried out by PseH and PseG within C. jejuni and H. pylori.[20] 
Alternatively, in the Gram-positive bacterium Bacillus 
thuringiensisWKHELRV\QWKHVLVRIĮ-CMP-Pse5Ac7Ac 3 is carried 
out by seven enzymatic reactions, where WZR HQ]\PHV ³3HQ´
DQG ³3DO´ DUH UHTXLUHG WR SHUIRUP WKH 3VH% UDP-GlcNAc 5-
epimerase and 4,6-dehydratase roles.[21] This yields the PseC or 
Pam substrate 7, from which point the remainder of the pathway 
is analogous to that in C. jejuni and H. pylori. The biosynthesis 
of Pse derivatives have also been characterised including Į-
CMP-5-acetamido-7-N-(3-hydroxybutanoyl)-3,5,7,9-tetradeoxy-
L-glycero-L-manno-non-2-ulosonic acid (CMP-Pse5Ac7Hb 5) 
found within Sinorhizobium fredii HH103, where Pse5Ac7Hb 11 
makes up a homopolysaccharide K-antigen.[22] The biosynthesis 
in this plant symbiont begins with two enzymes,[14b] homologous 
to that of C. jejuni PseB and PseC. The pathways diverge at the 
third enzyme, where in S. fredii the primary amine of C7 in 8 is 
derivatised with a 3-hydoxybutyryl (Hb) group by the acyl 
transferase RkpP, in place of an N-acetylation that occurs in 
Pse5Ac7Ac 2 biosynthesis. The remainder of the CMP-
Pse5Ac7Hb 5 pathway, comprises three subsequent enzymes 
homologous to those of the CMP-Pse5Ac7Ac pathway. 
0RVW UHFHQWO\ WKH Į-CMP-5-acetamido-7-N-formyl-3,5,7,9-
tetradeoxy-L-glycero-L-manno-non-2-ulosonic acid (CMP-
Pse5Ac7Fm 6) biosynthetic pathway from Gram-positive 
Anoxybacillus kamchatkensis has also been partially 
elucidated.[23] This pathway requires six-enzymes, 
demonstrating that a six-enzyme pathway is not an exclusive 
feature of Gram-negative species. The activities of the first three 
enzymes, PseB, PseC and PseJ were confirmed in vitro. PseB 
and PseC were shown to function similarly to their Gram-
negative homologues to produce amine 8. In a one-pot three 
enzyme synthesis, the formyl donor N10-formyltetrahydrofolate 
(N10-fTHF) was then used to formylate the C4 amine of 8 to 
produce UDP-4,6-dideoxy-4-formamido-L-AltNAc 12. Three 
downstream enzymes have been putatively assigned as those 
required to produce CMP-Pse5Ac7Fm 6 from 12 in three steps 
analogous to those used in CMP-Pse5Ac7Ac 3 biosynthesis. 
There are currently no other examples of in vitro characterisation 
of enzymes involved in biosynthesis of Pse derivatives.  
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 In addition to Pse5Ac7Ac 2, the derivative 5-acetamido-7-
acetamidino-3,5,7,9-tetradeoxy-L-glycero-L-manno-non-2-
ulosonic acid (Pse5Ac7Am), is found on the flagella of C. 
jejuni.[24] While the 3-hydroxybutyryl and formyl substituents 
present in 5 and 6 are installed early in the biosynthetic pathway, 
it is currently unclear at which point in the pathway the 
acetamido group is converted into to an acetamidino group, but 
it has been suggested that Pse5Ac7Ac 2 or CMP-Pse5Ac7Ac 3 
may be a late stage substrate for the candidate enzyme, 
PseA.[24] It is notable that both early and late stage 
functionalization approaches have been explored in the 
chemical derivatisation of Pse glycans vide infra.  
The elucidation of the CMP-Pse5Ac7Ac 3 biosynthetic 
pathway has been complemented by detailed biochemical and 
structural characterisation of the individual enzymes from H. 
pylori and C. jejuni,[9b] and this has enabled the one-pot multi-
enzyme synthesis of Pse5Ac7Ac 2 and CMP-Pse5Ac7Ac 3.[18a] 
To date however there is very limited knowledge of 
glycosyltransferases (GTs) which utilise CMP-Pse donors 
(pseudaminyltransferases, PseTs), with only a handful of genes 
putatively assigned as PseTs based upon sequence homology 
to sialyltransferases (SiaTs) or transferases that process 
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VWUXFWXUDOO\UHODWHGĮ-keto sugars.[9g, 25] Furthermore, none of the 
proteins encoded by the putative PseTs have been functionally 
characterised in vitro, precluding the use of enzymes for 
accessing Pse-glycosides, which are an essential requirement 
for biological studies into the significance of Pse. Thus chemical 
synthesis of these glycans has been adopted as an alternative 
approach. 
4. Chemical approaches to the synthesis of 
pseudaminic acids and glycosides 
Chemical synthetic routes to complex molecules are often 
inspired by biosynthesis pathways and Pse glycans are no 
different. Whilst Pse5Ac7Ac 2 is fairly similar to commercially 
available Neu5Ac 1, its synthesis has proved more challenging. 
Many of the complications in the synthesis of Pse can be 
attributed to the epimeric stereochemistry at C5, C7 and C8 and 
deoxygenation at C9. To date, all literature approaches to 
chemical synthesis can be classified as one of three strategies: 
i) synthetic conversion from an analogous nulO acid, which 
requires inversion of several stereocentres; ii) de novo synthesis 
from a four carbon chiral precursor; or iii) a biomimetic approach 
targeting synthesis of the biosynthetic intermediate 6-deoxy-
AltdiNAc 10, or analogues, followed by an aldol-type 
condensation.  
The first publication reporting the synthesis of Pse5Ac7Ac 
2 came from Tsvetkov and co-workers in 2001,[26] 17 years after 
the discovery of Pse5Ac7Ac 2 by Knirel,[10] and falls into the 
latter category. The authors used an approach that was 
analogous to the strategies previously deployed in the synthesis 
of sialic acids, where a six-carbon scaffold is subjected to an 
aldol-type condensation reaction with oxaloacetic acid, followed 
by decarboxylation, to yield the nine-carbon product.[27] In this 
synthesis 2,4-diacetamido-2,4,6-trideoxy-L-allose 13 (Scheme 2) 
was as used the six-carbon intermediate, an epimer of naturally 
occurring biosynthetic intermediate 10. A multi-step synthesis 
beginning from 3,4-di-O-benzoyl-ȕ-L-rhamnopyranoside 14 was 
employed in the synthesis of diacetamido sugar 13, and 
proceeded through the key diequatorial azide 15. The 
condensation of reducing sugar 13 with oxaloacetic acid 
produced three nonulosonic acids, 16, Pse5Ac7Ac 2 and 17, in 
8%, 3% and 1% yields respectively. The authors remarked that 
the stereoselectivity of the condensation reaction was 
unexpected, and the harsh conditions of the reaction 
presumably resulted in initial epimerisation at C2 in 13. Although 
a landmark as the first chemical synthesis of Pse5Ac7Ac 2, the 
low yield of the desired product, left clear room for improvement. 
Ito and co-workers reported the next chemical synthesis of 
Pse5Ac7Ac 2 (Scheme 3)[28] via biosynthetic intermediate 6-
deoxy-L-AltdiNAc 10 from inexpensive starting material N-acetyl-
glucosamine 18 (GlcNAc). GlcNAc 18 was manipulated into ޱ-
idosamine 19, a precursor of the biomimetic intermediate 21. 
The initial strategy proposed proceeding through azide inversion 
at C4 in 19, but was unsuccessful. Therefore an alternative 
strategy was employed using a Dess-Martin periodane (DMP) 
oxidation of 19 to afford ketone 20, followed by oxime formation. 
Reduction with samarium iodide, and immediate acetylation of 
the resultant free N5 amine afforded diacetamido 21 in 66% 
yield.  The benzyl protected biosynthetic precursor 22 was then 
accessed through hydrogenolysis, and subjected to the key 
synthetic step, an indium mediated allylation using 
bromomethylacrylate ester, which yielded a mixture of both anti 
23 and syn 24 (5:4) chain elongated products in 77% yield. 
Subsequent cyclisation to afford the ring closed 9-carbon 
Pse5Ac7Ac 2 and 4-epi-Pse5Ac7Ac 17, by ozonolysis and 
saponification proceeded in excellent yield for both isomers. The 
obvious limitation of this route was the low levels of 
Scheme 2. Tsvetkov and co-workers approach to Pse5Ac7Ac 2. 
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stereocontrol achieved in the allylation, which could not be 
improved.  
However, enough Pse5Ac7Ac 2 was accessed to enable 
the first chemical glycosylation of a Pse glycosyl donor to be 
performed (Scheme 4). The authors subjected dibenzyl 
phosphate donor 25 to a TMSOTf mediated glycosylation in 
dichloromethane (DCM) using methyl glycoside acceptor 26, 
and isolated the D-glycoside 27 in 35% yield, however there was 
also significant formation of the glycal byproduct 28.  
In 2014 Kiefel and co-workers reported the synthesis of a 
Pse5Ac7Ac analogue, 8-epi-Pse5Ac7Ac methyl ester 29, over 
13 steps.[29] Their initial retrosynthetic analysis highlighted sialic 
acid 2-keto-3-deoxy-D-glycero-D-galacto-nonulosonic acid (KDN) 
as a potential precursor that would furnish the correct 
stereochemistry required at C5 and C7 through initial azide 
inversion. However, due to difficulties in obtaining KDN from 
commercial sources, the authors first had to synthesise the 
methyl ester protected KDN 30 from protected Neu5Ac 31 via a  
Zbiral deamination[30] (Scheme 5) of the N5 equatorial acetamido 
group and Zemplen deprotection. Following a number of  
protecting group manipulations, key diol 32 was produced. The 
diol was then subjected to a parallel inversion, proceeding 
through the bis-triflate intermediate 33, before treatment with 
sodium azide yielded the diazido derivative 34, bearing the 
correct Pse stereochemistry at C5 and C7. Following 
optimisation of conditions the diazido compound 34 was reduced 
and bis-acetylated before concomitant acetal and TBS 
protection and then deoxygenation of the primary alcohol, via 
iodination and Pd(OH)2 catalysed reduction to afford the 8-epi-
Pse5Ac7Ac methyl ester 29 (Scheme 5). 
Two years on from reporting the synthesis of 8-epi-
Pse5Ac7Ac 29, Kiefel, Payne and co-workers disclosed the 
synthesis of Pse5Ac7Ac 2 in an overall 17-step sythesis from 
Neu5Ac 1 (Scheme 6).[31] This strategy also required the 
synthesis of diazido acetonide 34, established by Kiefel,[29] which 
was then subjected to acetal clevage and selective TBS 
reprotection of the primary alcohol at O9. The free O7 hydroxy of 
35 was then available for DMP oxidation, followed by 
stereoselective reduction with BH3yTHF, and protection to deliver 
the C8 epimerised acetyl 36. From therein the endgame 
involved similar protecting group manipulations, and an 
iodination-deoxygenation strategy as employed in the 8-epi-
Pse5Ac7Ac methyl ester 29 synthesis. Culminating in hydrolysis 
and saponification to yield the parent Pse5Ac7Ac 2. 
 
 Dhakal and Crich also developed a synthesis of Pse 
sugars using Neu5Ac 1 as a starting material.[32] A Zbrial 
deamination by nitrosylation was similarly employed, on this 
occasion using a thioadamantyl (Ada) donor 37 as the substrate 
(Scheme 7). Levulinic acid was employed as the nucleophile 
and advantageously furnished a protected hydroxyl 38 in 55% 
overall yield. In exploring this reaction the authors noted that the 
Scheme 6. Synthesis of Pse5Ac7Ac 2 from Neu5Ac 1, proceeding through 
key diazido intermediate 34. 
Scheme 4. Glycosylation of dibenzyl phosphite Pse glycosyl donor 25. 
Scheme 5. Synthesis of 8-epi-Pse5Ac7Ac methyl ester 29 as reported by 
Kiefel and co-workers. 
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deamination reaction was more stereoselective when the C9 
position was still functionalised with an oxygen. They therefore 
opted to deaminate 37 before performing protecting group 
manipulations followed by inversion of the hydroxyl 
stereochemistry at C8 of 39 by triflation and nucleophilic attack. 
Deoxygenation of C9 was then achieved through iodination and 
subsequent hydrogenation of iodide 40 in 91% yield. Three 
further protecting group manipulations yielded the diol 41, which 
was then subjected to double parallel inversion through triflation 
and attack with sodium azide, affording the diazido SAda donor 
42 bearing the correct Pse stereochemistry at positions 5 and 7 
(Scheme 7). Glycosylation of this donor under NIS/TfOH 
activation (Scheme 8) with benzyl alcohol as an acceptor 
afforded the benzyl glycoside 43 in an excellent 89% yield as 
only the E-anomer. The benzyl glycoside 43 was then reduced 
and acetylated at N5 and N7 in a single step, before 
deprotection by ester hydrolysis and hydrogenation in two steps 
to afford Pse5Ac7Ac 2 in 81% yield. The authors noted that the 
E-selectivity achieved in a dichloromethane-acetonitrile (2:1) 
solvent mix at í78 °C using benzyl alcohol as an acceptor was 
also observed with more hindered glycosyl acceptors, and 
attributed the exquisite equatorial selectivity to the preference for 
the side chain in Pse glycans to adopt a trans,gauche 
conformation. Finally the authors also demonstrated that 
regioselective deprotection of the 5-azido and 7-azido positions 
could be achieved under orthogonal conditions, enabling the late 
stage selective functionalisation and differentiation of the two 
positions, as is sometimes observed in the biosynthesis of Pse 
in vivo.  
 Li and co-workers developed an alternative de novo 
strategy to access Pse5Ac7Ac 2 and Pse glycosides (Scheme 
9), beginning from the readily avaliable chiral precursor L-
threonine,[33] which was epimerised to L-allo threonine, and 
transformed into aldehyde 44. In an analogous strategy to that 
employed for the synthesis of an epimeric nonulosonic acid- 
legionaminic acid,[34] the authors opted to deploy the aldehyde in 
a diastereoselective aldol-type condensation to build the 6-
deoxy AltdiNAc biosynthetic backbone, which could then be 
subjected to a chain elongation by the indium mediated allylation, 
pioneered in the approach used by Ito and co-workers.[28] The 
key step in this synthesis was the condensation of the aldehyde 
44 and glycine thioester isonitrile 45, which required significant 
optimisation to achieve diastereocontrol to deliver the desired 
diastereomer 46 over the undesired 47 in a 5:1 ratio, with the 
use of lithium triflate as a Lewis acid and a dicholoroethane 
(DCE)-dichloromethane solvent mix proving essential. Following 
triethylsilane reduction of the thioester 46 to an aldehyde, and 
unexpected but concomitant TES protection of a hydroxyl, 
poorer levels of the required anti-selectivity were then achieved 
in the indium mediated allylation (syn/anti = 3:1-5:1) than those 
reported by Ito using an unprotected substrate (syn/anti = 4:5, 
Scheme 3). Therefore, the authors opted to oxidise the newly 
formed alcohol 48 to a ketone using DMP, remove the TES 
protecting group from the adjacent position and then reduce the 
ketone with sodium triacetoxy borohydride to selectively afford 
only the desired anti-stereoisomer 49 in 90% yield over 3 steps. 
Following a number of protecting group manipulations, the N-
Troc protected alkene 50 was then subjected to ozonolysis and 
ring closing, followed by acetylation to yield protected 
Pse5Ac7Ac 51. The isopropyl ester 51 could then be 
deprotected over multiple steps to afford the parent Pse5Ac7Ac 
sugar 2, but the protected precursor was also a useful 
intermediate en route to Pse thioglycoside donors for chemical 
glycosylation studies.  
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Scheme 7. 'KDNDODQG&ULFK¶V=ELUDOGHDPLQDWLRQRI3VHWKLRJO\FRVLGH37 with 
a levunoic acid nucleophile enabled expedient synthesis of diazido donor 42.  
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Scheme 8. Glycosylation of diazido Pse donor 42 with benzyl alcohol en route 
to the synthesis of Pse5Ac7Ac 2.  
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 Following significant exploration of Pse glycosylation 
protocols, the authors set out to perform the first total synthesis 
of a complex Pse glycan and synthesised STol donor 52, from 
51, bearing a benzyl protected protected 3-hydroxyl-butyryl 
group (Scheme 10). This pseudo protecting group was chosen 
for glycosylations because it could potentially undergo O-N acyl 
transfer to afford the N5 substituent of the known trisaccharide 
53, which is present on the pili of P. aeruginosa strain 1244.[33] 
When this donor was incubated with protected xylose-FucNAc 
disaccharide acceptor 54 and activated with p-TolSCl/AgOTf the 
desired D-linked trisaccharide 55 was formed with complete 
stereoselectivity in 66% yield. Subsequent TBAF mediated Troc 
deprotection at N5 on the Pse sugar triggered the anticipated 
transfer of the (R)-3-benzyloxybutyryl group from O4 to N5, as 
required in the target glycan. Reduction and acetylation of the 
azido group on the FucNAc moiety set the stage for the 
culmination of this tour de force synthesis by removal of all 
protecting groups and formylation of N7 in three steps to yield 
the final trisaccharide 53. 
 In a subsequent study Li and co-workers noted that 
the stereocontrol observed in glycosylation using the Pse STol 
donor bearing the N5-Troc/N7-Cbz protecting group combination 
(as in 52) was dependant on the acceptor,[35] with reactive 
acceptors such as benzyl alcohol alternatively affording the E-
anomer with complete stereocontrol. Therefore they explored 
whether tuning the reactivity of the thioglycoside aglycon could 
affect stereocontrol, focussing specifically on the SEt donor 56, 
and less reactive SAda donor 57, in NIS/TfOH mediated 
glycosylations (Scheme 11). All glycosylations proceeded in 
excellent yield but the authors noted that the SEt donor 56 gave 
moderate Dselectivity in the synthesis of Pse glycosides 58, 
while the E-anomer was generally favoured by the SAda donor 
57. However the overall selectivity was seemingly still acceptor d  
ependent as demonstrated by glycosylation of serine acceptor 
59 which favoured D-glycoside formation with both donors. 
Taking inspLUDWLRQ IURP 'KDNDO DQG &ULFK¶V XVH RI DQ D]LGR
substituted Pse donor,[32] the authors next screened the modifed 
N5-azido SAda donor 60, which lacked the potential participating 
Troc group, in an attempt to maximise E-stereoselectivity 
(Scheme 12). On this occasion NIS/TfOH activation in 
dichloromethane-acetonitrile solvent mix afforded disaccharides 
61 with complete stereoselectivity. Furthermore, the same donor 
showed bimodal reactivity and afforded disaccharides 61 with 
complete D-stereoselectivity when subjected to glycosylation 
under similar activating conditions but in a dichloromethane-N,N- 
dimethylformamide (DMF) solvent mix. The authors proposed 
that DMF forms a transient glycosyl imidate intermediate, which 
is converted to the reactive E-imidate prior to SN2-like 
glycosylation from the D-face, in a Curtin-Hammett kinetic 
scenario. Notably the glycosylations of N5-Troc SAda donor 57 
were also completely D-stereoselective if DMF was used as an 
additive. The power of the E-selective strategy was showcased 
by elaborating the E-disaccharide product of glycosylation with 
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Scheme 9. Li and co-ZRUNHU¶Vde novo synthesis of Pse5Ac7Ac from an L-allo 
threonine starting material.  
Scheme 10. Total synthesis of Pse containing pili trisaccharide 53 from P. 
aeruginosa 1255.  
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acceptor 62, into a trisaccharide which mimics the skeletal 
framework of a repeating LPS unit from a Pse presenting 
bacterium.[35] 
 
5. Chemoenzymatic approaches to the 
synthesis of pseudaminic acid 
Notably, several of the total syntheses of Pse glycans reported 
required installation of azido groups. This functional group may 
also be used as bioorthogonal handles when present on Pse 
derivatives, as demonstrated by the work of Tanner and 
colleagues who used a chemoenzymatic approach to azido-
modify C. jejuni flagella (Scheme 13).[36] Firstly enzymes PseB 
and PseC were employed in vitro to afford amine 8 from the 
UDP-GlcNAc 4 biosynthetic starting material. Following 
chemically acetylation with chloroacetic anhydride, the PseG 
substrate analogue 63 was produced in a chemoenzymatic 
process. The UDP group of 63 could still then be hydolysed by 
PseG yielding reducing sugar 64 which was then treated with 
sodium azide to yield the altrose diamino functionalised sugar 65, 
which is an azido analogue of key biosynthetic intermediate 6-
deoxy-AltDiNAc 10 (Scheme 1). The subsequent Pse 
biosynthesis transformations  proved promiscuous enough to 
utilise this azido analogue when it was fed to C. jejuni cells in 
growth media. Following in vivo biosynthetic transformation by 
PseI and PseF, and presumably as yet uncharacterised glycosyl 
transferases, the azido group incorporated into the Pse 
backbone could then be visualised on C. jejuni flagella by a 
Staudinger ligation using a biotin-linked reagent and western 
blot using an avidin-horseradishperoxidase (HRP) 
chemiluminescent reporter system. 
 Li and co-workers built upon this approach and also the 
methodology used in their total synthesis of Pse5Ac7Ac 2, by 
using L-allo-threonine as the starting material for synthesis of 6-
deoxy-AltDiNAc analogues bearing azido groups at the N5 or N7 
positions.[37] Supplementing rich growth media for P. aeruginosa, 
A. baumannii and Vibrio vulnificus with both these Pse 
biosynthetic precursors, enabled Cu-free click fluorescent 
visualisation of any resulting cell-surface azido-modified Pse. 
Studies confirmed that the LPS had been labelled within some of 
the P. aeruginosa strains screened, indicating that azido labelled 
Scheme 11. Pse glycosylations of SEt donor 56 and SAda donor 57  
Scheme 12. Comparative stereoselective glycosylations of bimodal Pse donor 
60 under different activating conditions.  
Scheme 13. In vitro chemoenzymatic synthesis of bioorthogonal biosynthetic 
precursor 6-deoxy-AltNAc4Az 65, enables metabolic incorporation and 
biotinylation of azides on Pse5Ac7Az modified flagella. 
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Pse was present in the O-antigen. Further examination 
confirmed that only the N7-azido precursor allowed labelling in 
all organisms tested, which suggested that within the strains and 
serotypes tested, an enzyme downstream of PseG was unable 
to utilise N5-azido sugar. This study demonstrated that whilst 
chemoenzymatic synthesis of Pse glycans by metabolic 
engineering can provide valuable information in the biological 
relevance of Pse, the strategy is not infallible. 
 
6. Summary and Outlook 
In conclusion we have summarised the burgeoning work in the 
field of Pse synthesis. This non-mammalian sugar  is of 
increasing biological importance as an essential component in 
the cell surface glycoconjugates of a number of pathogenic 
bacteria, including the multidrug resistant P. aeruginosa, and A. 
baumannii, which are emerging causes of outbreaks of hospital 
acquired infections. Pioneering studies into the biosynthesis of 
Pse5Ac7Ac 2 in a number of bacteria have provided inspiration 
to synthetic carbohydrate chemists, who have recently reported 
the chemical synthesis of Pse5Ac7Ac and derivatives. These 
studies have also provided test-bed substrates to explore the 
nuances of Pse chemical glycosylation for the synthesis of more 
complex Pse glycosides. Such is the arduous challenge 
presented by Pse total chemical synthesis however, the use of 
enzymes in tandem with chemical synthesis has also proved 
increasingly attractive. Chemoenzymatic strategies demonstrate 
the benefits of utilising enzymes in synthesis due to their 
inherent regio- and stereoselectivity, but also demonstrate that a 
degree of enzyme promiscuity may be exploited. This potentially 
allows access to products ranging from naturally occurring 
Pse5Ac7Ac derivatives, to Pse bioorthogonal chemical probes, 
which will undoubtedly be used to study the biological relevance 
of Pse in the future. However the outstanding challenge in this 
field still remaining is to combine synthesis of Pse 
monosaccharides with enzymatic glycosylations, which will 
provide more routine access to complex glycans containing Pse 
sugars for in depth glycobiology studies. In order to achieve this 
goal the unexplored power of pseudaminyltransferase enzymes 
and other Pse processing enzymes must first be harnessed. 
Acknowledgements  
This work was supported by The University of York, the EPSRC 
(PhD award to E.K.F.P.) and The Rosetrees Trust (PhD award 
to H.C.). 
Keywords: Pse5Ac7Ac  chemical synthesis  carbohydrate 
chemistry  FKHPRHQ]\PDWLF pseudaminic acid 
 
MINIREVIEW          
11 
 
 
References 
 
[1] S. Hurtley, R. Service, P. Szuromi, Science 2001, 291, 2337. 
[2] aA. Varki, Glycobiology 2016, 27, 3-49; bA. Varki, Glycobiology 1993, 3, 97-130. 
[3] C. M. Szymanski, R. Yao, C. P. Ewing, T. J. Trust, P. Guerry, Mol. Microbiol. 1999, 32, 1022-1030. 
[4] B. Imperiali, Curr. Opin. Chem. Biol. 2019, 53, 1-8. 
[5] M. Zunk, M. J. Kiefel, RSC Adv. 2014, 4, 3413-3421. 
[6] H. N. Stephenson, D. C. Mills, H. Jones, E. Milioris, A. Copland, N. Dorrell, B. W. Wren, P. R. Crocker, D. Escors, M. Bajaj-Elliott, J. 
Infect. Dis. 2014, 210, 1487-1498. 
[7] T. Angata, A. Varki, Chem. Rev. 2002, 102, 439-470. 
[8] A. Varki, Glycobiology 1992, 2, 25-40. 
[9] aS. y. N. Senchenkova, J. J. Kenyon, T. Jia, A. V. Popova, M. M. Shneider, A. A. Kasimova, A. S. Shashkov, B. Liu, R. M. Hall, Y. 
A. Knirel, Carbohydr. Res. 2019, 479, 1-5; bA. I. M. Salah Ud-Din, A. Roujeinikova, Cell. Mol. Life Sci. 2018, 75, 1163-1178; cI. M. 
Lee, F.-L. Yang, T.-L. Chen, K.-S. Liao, C.-T. Ren, N.-T. Lin, Y.-P. Chang, C.-Y. Wu, S.-H. Wu, J. Am. Chem. Soc. 2018, 140, 
8639-8643; dM. B. Tomek, B. Janesch, D. Maresch, M. Windwarder, F. Altmann, P. Messner, C. Schaeffer, Glycobiology 2017, 27, 
555-567; eS. y. N. Senchenkova, A. V. Popova, A. S. Shashkov, M. M. Shneider, Z. Mei, N. P. Arbatsky, B. Liu, K. A. Miroshnikov, 
N. V. Volozhantsev, Y. A. Knirel, Carbohydr. Res. 2015, 407, 154-157; fS. y. N. Senchenkova, A. S. Shashkov, N. P. Arbatsky, M. 
M. Shneider, K. A. Miroshnikov, A. V. Popova, N. V. Volozhantsev, Y. A. Knirel, Carbohydr. Res. 2014, 391, 89-92; gJ. L. Parker, R. 
C. Lowry, N. A. S. Couto, P. C. Wright, G. P. Stafford, J. G. Shaw, Mol. Microbiol. 2014, 92, 258-272. 
[10] Y. A. Knirel, E. V. Vinogradov, V. L. L'Vov, N. A. Kocharova, A. S. Shashkov, B. A. Dmitriev, N. K. Kochetkov, Carbohydr. Res. 
1984, 133, C5-C8. 
[11] aT. L. Miller, M. J. Wolin, E. C. de Macario, A. J. Macario, App. Environ. Microbiol. 1982, 43, 227; bL. Kandiba, J. Eichler, FEMS 
Microbiol. Lett. 2013, 345, 110-120; cA. L. Lewis, N. Desa, E. E. Hansen, Y. A. Knirel, J. I. Gordon, P. Gagneux, V. Nizet, A. Varki, 
Proc. Nat. Acad. Sci. 2009, 106, 13552. 
[12] P. Castric, F. J. Cassels, R. W. Carlson, J. Biol. Chem. 2001, 276, 26479-26485. 
[13] aA. A. Kasimova, M. M. Shneider, N. P. Arbatsky, A. V. Popova, A. S. Shashkov, K. A. Miroshnikov, V. Balaji, I. Biswas, Y. A.  Knirel, 
Biochemistry (Moscow) 2017, 82, 483-489; bY. A. Knirel, N. A. Kocharova, A. S. Shashkov, B. A. Dmitriev, N. K. Kochetkov, E. S. 
Stanislavskii, G. M. Mashilova, Eur. J. Biochem. 1987, 163, 639-652; cY. A. Knirel, E. V. Vinogradov, A. S. Shashkov, B. A. 
Dmitriev, N. K. Kochetkov, E. S. Stanislavskii, G. M. Mashilova, Eur. J. Biochem. 1986, 157, 129-138. 
[14] aP. Thibault, S. M. Logan, J. F. Kelly, J.-R. Brisson, C. P. Ewing, T. J. Trust, P. Guerry, J. Biol. Chem. 2001, 276, 34862-34870; bI. 
Margaret, J. C. Crespo-Rivas, S. Acosta-Jurado, A. M. Buendia-Claveria, M. T. Cubo, A. Gil-Serrano, J. Moreno, P. S. Murdoch, M. 
A. Rodriguez-Carvajal, D. N. Rodriguez-Navarro, J. E. Ruiz-Sainz, J. Sanjuan, M. J. Soto, J. M. Vinardell, Mol. Plant-Microbe 
Interact. 2012, 25, 825-838. 
[15] M. Schirm, E. C. Soo, A. J. Aubry, J. Austin, P. Thibault, S. M. Logan, Mol. Microbiol. 2003, 48, 1579-1592. 
[16] S. Goon, J. F. Kelly, S. M. Logan, C. P. Ewing, P. Guerry, Mol. Microbiol. 2003, 50, 659-671. 
[17] aK. M. Ottemann, A. C. Lowenthal, Infect. Immun. 2002, 70, 1984; bP. Guerry, Trends Microbiol. 2007, 15, 456-461. 
[18] aI. C. Schoenhofen, D. J. McNally, J.-R. Brisson, S. M. Logan, Glycobiology 2006, 16, 8C-14C; bE. S. Rangarajan, A. Proteau, Q. 
Cui, S. M. Logan, Z. Potetinova, D. Whitfield, E. O. Purisima, M. Cygler, A. Matte, T. Sulea, I. C. Schoenhofen, J. Biol. Chem. 2009, 
284, 20989-21000; cJ. P. Morrison, I. C. Schoenhofen, M. E. Tanner, Bioorg. Chem. 2008, 36, 312-320; dI. C. Schoenhofen, D. J. 
McNally, E. Vinogradov, D. Whitfield, N. M. Young, S. Dick, W. W. Wakarchuk, J.-R. Brisson, S. M. Logan, J. Biol. Chem. 2006, 281, 
723-732; eF. Liu, M. E. Tanner, J. Biol. Chem. 2006, 281, 20902-20909; fR. K. Obhi, C. Creuzenet, J. Biol. Chem. 2005, 280, 
20902-20908. 
[19] I. C. Schoenhofen, V. V. Lunin, J.-P. Julien, Y. Li, E. Ajamian, A. Matte, M. Cygler, J.-R. Brisson, A. Aubry, S. M. Logan, S. Bhatia, 
W. W. Wakarchuk, N. M. Young, J. Biol. Chem. 2006, 281, 8907-8916. 
[20] S. M. B. Tabei, P. G. Hitchen, M. J. Day-Williams, S. Merino, R. Vart, P.-C. Pang, G. J. Horsburgh, S. Viches, M. Wilhelms, J. M. 
Tomas, A. Dell, J. G. Shaw, J. Bacteriol. 2009, 191, 2851-2863. 
[21] Z. Li, S. Hwang, J. Ericson, K. Bowler, M. Bar-Peled, J. Biol. Chem. 2015, 290, 691-704. 
[22] A. M. Gil-Serrano, M. A. RodrÍGuez-Carvajal, P. Tejero-Mateo, J. L. Espartero, M. Menendez, J. Corzo, J. E. Ruiz-Sainz, A. M. 
BuendÍA-ClaverÍA, Biochem. J. 1999, 342, 527-535. 
[23] J. M. Reimer, I. Harb, O. G. Ovchinnikova, J. Jiang, C. Whitfield, T. M. Schmeing, ACS Chem. Biol. 2018, 13, 3161-3172. 
[24] D. J. McNally, J. P. M. Hui, A. J. Aubry, K. K. K. Mui, P. Guerry, J.-R. Brisson, S. M. Logan, E. C. Soo, J. Biol. Chem. 2006, 281, 
18489-18498. 
[25] aG. Sulzenbacher, V. Roig-Zamboni, R. Lebrun, Y. Guerardel, D. Murat, P. Mansuelle, N. Yamakawa, X.-X. Qian, R. Vincentelli, Y. 
Bourne, L.-F. Wu, F. Alberto, Environ. Microbiol. 2018, 20, 228-240; bL. B. van Alphen, M. Wuhrer, N. M. C. Bleumink-Pluym, P. J. 
Hensbergen, A. M. Deelder, J. P. M. van Putten, Microbiology 2008, 154, 3385-3397. 
[26] Y. E. Tsvetkov, A. S. Shashkov, Y. A. Knirel, U. Zähringer, Carbohydr. Res. 2001, 335, 221-243. 
[27] R. Shirai, H. Ogura, Tetrahedron Lett. 1989, 30, 2263-2264. 
[28] Y. J. Lee, A. Kubota, A. Ishiwata, Y. Ito, Tetrahedron Lett. 2011, 52, 418-421. 
[29] M. Zunk, J. Williams, J. Carter, M. J. Kiefel, Org. Biomol. Chem. 2014, 12, 2918-2925. 
[30] R. Christian, G. Schulz, H. H. Brandstetter, E. Zbiral, Carbohydr. Res. 1987, 162, 1-11. 
[31] J. T. Williams, L. Corcilius, M. J. Kiefel, R. J. Payne, J. Org. Chem. 2016, 81, 2607-2611. 
[32] B. Dhakal, D. Crich, J. Am. Chem. Soc. 2018, 140, 15008-15015. 
[33] H. Liu, Y. Zhang, R. Wei, G. Andolina, X. Li, J. Am. Chem. Soc. 2017, 139, 13420-13428. 
[34] S. Matthies, P. Stallforth, P. H. Seeberger, J. Am. Chem. Soc. 2015, 137, 2848-2851. 
[35] R. Wei, H. Liu, A. H. Tang, R. J. Payne, X. Li, Org. Lett. 2019, 21, 3584-3588. 
[36] F. Liu, A. J. Aubry, I. C. Schoenhofen, S. M. Logan, M. E. Tanner, ChemBioChem 2009, 10, 1317-1320. 
[37] G. Andolina, R. Wei, H. Liu, Q. Zhang, X. Yang, H. Cao, S. Chen, A. Yan, X. D. Li, X. Li, ACS Chem. Biol. 2018, 13, 3030-3037. 
 
 
MINIREVIEW          
12 
 
 Entry for the Table of Contents 
 
 
 
Pse sugars to order: In this minireview we summarise work in the field of pseudaminic acid (Pse) synthesis. This non-mammalian 
sugar is of increasing biological importance as an essential component in cell surface glycoconjugates of a number of pathogenic 
bacteria. Pioneering studies into Pse5Ac7Ac biosynthesis have provided inspiration to carbohydrate chemists, who have recently 
reported the chemical and chemoenzymatic synthesis of Pse glycans.  
 
